{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T22:25:25Z","timestamp":1765319125898,"version":"3.46.0"},"reference-count":27,"publisher":"BMJ","issue":"6393","license":[{"start":{"date-parts":[[1983,9,3]],"date-time":"1983-09-03T00:00:00Z","timestamp":431395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J (Clin Res Ed)"],"published-print":{"date-parts":[[1983,9,3]]},"abstract":"<jats:p>The aetiology of retroperitoneal fibrosis is unknown. From time to time different drugs have been suggested as a cause, including beta adrenoceptor blocking agents. The notes of 100 hospital inpatients in whom retroperitoneal fibrosis had been diagnosed were surveyed to identify the date of onset of symptoms, the drugs prescribed before then, and the blood pressures on admission. Seventy one patients had diastolic pressures on admission of 90 mm Hg or more and 53 of these had pressures of at least 100 mm Hg despite 14 of the patients taking anti-hypertensive drugs at the time. Six patients had received beta-adrenoceptor blocking agents before the onset of symptoms and a further 24 received them subsequently. In particular, three patients continued treatment for at least six years after the diagnosis was made and surgery performed, without suffering a recurrence of retroperitoneal fibrosis. Besides beta-adrenoceptor drugs, diuretics and other hypotensive drugs were taken in amounts reflecting the pattern of drug use among hypertensive patients generally. Rather than being causal agents, the antihypertensive drugs were probably being used to treat hypertension associated with the retroperitoneal fibrosis, and our findings suggest that beta-adrenoceptor blocking agents do not cause retroperitoneal fibrosis.<\/jats:p>","DOI":"10.1136\/bmj.287.6393.639","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T11:00:59Z","timestamp":1238670059000},"page":"639-641","source":"Crossref","is-referenced-by-count":21,"title":["Do beta-adrenoceptor blocking drugs cause retroperitoneal fibrosis?"],"prefix":"10.1136","volume":"287","author":[{"given":"J P","family":"Pryor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W M","family":"Castle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D C","family":"Dukes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J C","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M E","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J L","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1983,9,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-5347(17)63635-8","article-title":"Idiopathic retroperitoneal fibrosis: a discussion of the aetiology","volume":"94","author":"JK, I.Ormand","year":"1965","unstructured":"I Ormand JK. Idiopathic retroperitoneal fibrosis: a discussion of the aetiology. J Urol 1965;94:385.","journal-title":"J Urol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1056\/NEJM196401092700202","article-title":"Methysergide for prevention of headache: experience in 500 patients over 3 years","volume":"270","author":"Graham, JR","year":"1964","unstructured":"Graham JR. Methysergide for prevention of headache: experience in 500 patients over 3 years. N EnglJ Med 1964;270:67-72.","journal-title":"N EnglJ Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0022-5347(17)59635-4","article-title":"Retroperitoneal fibrosis and ergot derivatives","volume":"112","author":"Stecker, J.F.; Rawls, H.P.; Devine, C.J.","year":"1974","unstructured":"Stecker JF, Rawls HP, Devine CJ, et al. Retroperitoneal fibrosis and ergot derivatives. J Urol 1974; 112:30-2.","journal-title":"J Urol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/014107687907200703","article-title":"Retroperitoneal fibrosis","volume":"72","author":"Kinder, C.H.","year":"1979","unstructured":"Kinder CH. Retroperitoneal fibrosis. J R Soc Med 1979;72:485-6.","journal-title":"J R Soc Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0140-6736(75)92733-6","article-title":"Retroperitoneal fibrosis during treatment with methyldopa","volume":"ii:","author":"Iversen, B.M.; Nordahl, E.; Thunold, S.","year":"1975","unstructured":"Iversen BM, Nordahl E, Thunold S, et al. Retroperitoneal fibrosis during treatment with methyldopa. Lancet 1975;ii:302-4.","journal-title":"Lancet"},{"key":"ref_6","first-page":"76","article-title":"Analgesic abuse, ureteric obstruction, and retroperitoneal fibrosis","volume":"ii:","author":"Lewis, C.T.; Molland, E.A.; Marshall, V.R.","year":"1975","unstructured":"Lewis CT, Molland EA, Marshall VR, et al. Analgesic abuse, ureteric obstruction, and retroperitoneal fibrosis. Br MedJ 1975;ii:76-8.","journal-title":"Br MedJ"},{"key":"ref_7","article-title":"Retroperitoneal fibrosis after treatment with atenolol. Br MedJr 1978","author":"Doherty CC, McGeown MG, Donaldson RA","year":"1786","unstructured":"Doherty CC, McGeown MG, Donaldson RA. Retroperitoneal fibrosis after treatment with atenolol. Br MedJr 1978;ii:1786."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/bmj.280.6217.864-b","article-title":"Retroperitoneal fibrosis associated with atenolol","volume":"7","author":"Johnson, J.N.; McFarland, J.B.","year":"1980","unstructured":"Johnson JN, McFarland JB. Retroperitoneal fibrosis associated with atenolol. Br Med 7 1980;280:864.","journal-title":"Br Med"},{"key":"ref_9","first-page":"1459","article-title":"Retroperitoneal fibrosis associated with metoprolol. Br MedJ 1982; 284: 83-4. '(' McCluskey DR, Donaldson RA, McGeown MG. Oxprenolol and retroperitoneal fibrosis","volume":"281","author":"Thompson, J.; Julian, D.G.","year":"1980","unstructured":"Thompson J, Julian DG. Retroperitoneal fibrosis associated with metoprolol. Br MedJ 1982;284:83-4. '(' McCluskey DR, Donaldson RA, McGeown MG. Oxprenolol and retroperitoneal fibrosis. Br MedJ 1980;281:1459-60.","journal-title":"Br MedJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-95-2-244_1","article-title":"Propranolol and retroperitoneal fibrosis","volume":"95","author":"Pierce, JR, Throstle; DC, Warner; J.J.","year":"1981","unstructured":"Pierce JR, Throstle DC, Warner JJ. Propranolol and retroperitoneal fibrosis. Ann Intern Med 1981;95:244.","journal-title":"Ann Intern Med"},{"key":"ref_11","first-page":"696","article-title":"Retroperitoneal fibrosis after treatment with propranolol","volume":"15","author":"Henri, L.; Groleau, M.","year":"1981","unstructured":"Henri L, Groleau M. Retroperitoneal fibrosis after treatment with propranolol. Drug Intelligence and Clinical Pharmacy 1981;15:696.","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"ref_12","first-page":"1085","article-title":"Retroperitoneal fibrosis associated with sotalol","volume":"285","author":"Laakso, M.; Arvala, I.; Tervonen, S.","year":"1982","unstructured":"Laakso M, Arvala I, Tervonen S, et al. Retroperitoneal fibrosis associated with sotalol. Br MedJ7 1982;285:1085-6."},{"key":"ref_13","first-page":"19","article-title":"Committee on Safety of Medicines. Retroperitoneal fibrosis and beta adrenoceptor antagonists","volume":"6","year":"1980","unstructured":"Committee on Safety of Medicines. Retroperitoneal fibrosis and beta adrenoceptor antagonists. Current Problems 1980;6:19.","journal-title":"Current Problems"},{"key":"ref_14","first-page":"250","article-title":"The clinical significance of retroperitoneal fibrosis","volume":"3","author":"Koep, L.; Zuidema, G.D.","year":"1977","unstructured":"Koep L, Zuidema GD. The clinical significance of retroperitoneal fibrosis. Surgery 1977;3:250-7.","journal-title":"Surgery"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5347(17)56223-0","article-title":"Idiopathic retroperitoneal fibrosis","volume":"122","author":"Lepor, H.; Walsh, P.C.","year":"1979","unstructured":"Lepor H, Walsh PC. Idiopathic retroperitoneal fibrosis. J Urol 1979;122: 1-6.","journal-title":"J Urol"},{"key":"ref_16","first-page":"159","article-title":"Retroperitoneal fibrosis. A radiological and follow-up study of fourteen cases","volume":"38","author":"Saxton, H.J.; Kilpatrick, F.R.; Kinder, C.H.","year":"1969","unstructured":"Saxton HJ, Kilpatrick FR, Kinder CH, et al. Retroperitoneal fibrosis. A radiological and follow-up study of fourteen cases. Q J Med 1969; 38:159.","journal-title":"Q J Med"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-5347(17)62752-6","article-title":"Idiopathic retroperitoneal fibrosis. Clinical experience with 15 cases","volume":"99","author":"Kerr, H.S.; Suby, H.I.; Videry, A.","year":"1968","unstructured":"Kerr HS, Suby HI, Videry A, et al. Idiopathic retroperitoneal fibrosis. Clinical experience with 15 cases. Y Urol 1968;99:575.","journal-title":"Y Urol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2214\/ajr.119.4.812","article-title":"Retroperitoneal fibrosis: an analysis of the clinical spectrum and roentgenographic signs","volume":"119","author":"Arger, P.H.; Stolz, J.L.; Miller, W.T.","year":"1973","unstructured":"Arger PH, Stolz JL, Miller WT. Retroperitoneal fibrosis: an analysis of the clinical spectrum and roentgenographic signs. AmJi Roentgen 1973;119: 812.","journal-title":"AmJi Roentgen"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1464-410X.1982.tb13610.x","article-title":"Hypertension and thromboembolism in idiopathic retroperitoneal fibrosis","volume":"54","author":"Mundy, A.R.; Kinder, C.H.; Flannery, J.F.","year":"1982","unstructured":"Mundy AR, Kinder CH, Flannery JF, et al. Hypertension and thromboembolism in idiopathic retroperitoneal fibrosis. Br J Urol 1982;54: 625-7.","journal-title":"Br J Urol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/bmj.284.6312.347-d","article-title":"Retroperitoneal fibrosis associated with metoprolol","volume":"7","author":"Mj, Mitchinson","year":"1982","unstructured":"Mitchinson Mj. Retroperitoneal fibrosis associated with metoprolol. Br Med 7 1982;284:347.","journal-title":"Br Med"},{"key":"ref_21","first-page":"1227","article-title":"Retroperitoneal fibrosis associated with atenolol. Br MedJ3","volume":"280","author":"Gavin, M.J.; Castle, W.M.; Cruickshank, J.M.","year":"1980","unstructured":"Gavin MJ, Castle WM, Cruickshank JM, et al. Retroperitoneal fibrosis associated with atenolol. Br MedJ3 1980;280:1227-8."},{"key":"ref_22","first-page":"229","article-title":"Adverse reactions of practolol","volume":"8","author":"Nicholls, J.T.","year":"1976","unstructured":"Nicholls JT. Adverse reactions of practolol. Ann Clin Res 1976;8:229-31.","journal-title":"Ann Clin Res"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jcp.23.8.681","article-title":"The pathology of idiopathic retroperitoneal fibrosis","volume":"23","author":"Mitchinson, M.J.","year":"1970","unstructured":"Mitchinson MJ. The pathology of idiopathic retroperitoneal fibrosis. J Clin Pathol 1970;23:681-9.","journal-title":"J Clin Pathol"},{"key":"ref_24","first-page":"539","article-title":"Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension","volume":"ii:","author":"Council, Medical Research","year":"1981","unstructured":"Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 1981;ii:539-43.","journal-title":"Lancet"},{"key":"ref_25","first-page":"\"1707","article-title":"Slow-Trasicor (sustained release oxprenolol hydrochloride 160 mg) in the treatment of essential hypertension: a multicentre evaluation of 4400 patients","volume":"247","author":"results, Mortality","year":"1982","unstructured":"Mortality results. YAMA 1982;247:1707-14. 27 Forrest WA. Slow-Trasicor (sustained release oxprenolol hydrochloride 160 mg) in the treatment of essential hypertension: a multicentre evaluation of 4400 patients. Br J Clin Pract 1977;31:181-6.","journal-title":"YAMA"},{"key":"ref_26","first-page":"102","article-title":"Atenolol in hypertension: a study of long-term therapy","volume":"53","author":"Zacharias, F.J.; Cuthbertson, P.J.R.; Prestt, J.","year":"1977","unstructured":"Zacharias FJ, Cuthbertson PJR, Prestt J. Atenolol in hypertension: a study of long-term therapy. Postgrad Medy 1977;53:102-10.","journal-title":"Postgrad Medy"},{"author":"Accepted 23June 1983)","key":"ref_27","unstructured":"(Accepted 23June 1983)"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.287.6393.639","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.287.6393.639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T22:22:38Z","timestamp":1765318958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.287.6393.639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,9,3]]},"references-count":27,"journal-issue":{"issue":"6393","published-online":{"date-parts":[[1983,9,3]]},"published-print":{"date-parts":[[1983,9,3]]}},"alternative-id":["10.1136\/bmj.287.6393.639"],"URL":"https:\/\/doi.org\/10.1136\/bmj.287.6393.639","relation":{},"ISSN":["0007-1447","1468-5833"],"issn-type":[{"type":"print","value":"0007-1447"},{"type":"electronic","value":"1468-5833"}],"subject":[],"published":{"date-parts":[[1983,9,3]]}}}